Player FMアプリでオフラインにしPlayer FMう!
MIRA Pharmaceuticals, Inc. Erez Aminov, CEO
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
150 つのエピソード
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
150 つのエピソード
すべてのエピソード
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。